Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2009

01.11.2009 | Case Report

Uterine cervical carcinosarcoma with heterologous mesenchymal component: a case report and review of the literature

verfasst von: Kyuichi Kadota, Reiji Haba, Masashi Ishikawa, Yoshio Kushida, Naomi Katsuki, Toshitetsu Hayashi, Yumi Miyai, Kenji Bando, Atsuko Shiota, Toshiyuki Hata

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Carcinosarcomas of the uterine cervix are very rare. Most of them have a homologous mesenchymal component, and cervical carcinosarcomas with a heterologous mesenchymal component are limited to nine cases.

Case report

A 61-year-old Japanese woman was admitted to the hospital for treatment of a ureteral stone. Imaging studies detected an indistinct cervical mass. A histopathological diagnosis of the cervical biopsy was a carcinosarcoma. A total abdominal hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy was carried out upon a diagnosis of stage Ib1 cervical carcinosarcoma. Microscopically, the cervical mass revealed a carcinosarcoma consisting of endometrioid adenocarcinoma and chondrosarcoma. Immunohistochemically, p53 was positive in the epithelial and mesenchymal components. Postoperatively, the patient underwent radiation and chemotherapy. She is alive with no evidence of recurrence 5 years and 10 months after the operation.

Conclusion

We suppose that the similar proportion of p53 overexpression in both the epithelial and mesenchymal components may be one of the findings explaining the histogenesis of this tumor by combination theory.
Literatur
1.
Zurück zum Zitat Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9:1–19. doi:10.1097/00004347-199001000-00001 PubMedCrossRef Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9:1–19. doi:10.​1097/​00004347-199001000-00001 PubMedCrossRef
4.
Zurück zum Zitat Clement PB, Zubovits JT, Young RH, Scully RE (1998) Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol 17:211–222. doi:10.1097/00004347-199807000-00004 PubMed Clement PB, Zubovits JT, Young RH, Scully RE (1998) Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol 17:211–222. doi:10.​1097/​00004347-199807000-00004 PubMed
5.
Zurück zum Zitat Takeshima Y, Amatya VJ, Nakayori F, Nakano T, Iwaoki Y, Daitoku K, Inai K (2002) Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection. Int J Gynecol Pathol 21:186–190. doi:10.1097/00004347-200204000-00013 PubMedCrossRef Takeshima Y, Amatya VJ, Nakayori F, Nakano T, Iwaoki Y, Daitoku K, Inai K (2002) Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection. Int J Gynecol Pathol 21:186–190. doi:10.​1097/​00004347-200204000-00013 PubMedCrossRef
11.
12.
Zurück zum Zitat Yannacou N, Gerolymatos A, Parissi-Mathiou P, Chranioti S, Perdikis T (2000) Carcinosarcoma of the uterine cervix composed of an adenoid cystic carcinoma and a homologous stromal sarcoma. A case report. Eur J Gynaecol Oncol 21:292–294PubMed Yannacou N, Gerolymatos A, Parissi-Mathiou P, Chranioti S, Perdikis T (2000) Carcinosarcoma of the uterine cervix composed of an adenoid cystic carcinoma and a homologous stromal sarcoma. A case report. Eur J Gynaecol Oncol 21:292–294PubMed
14.
Zurück zum Zitat Iwasaki T, Sata T, Sugase M, Sato Y, Kurata T, Suzuki K, Ohmoto H, Iwamoto S, Matsukura T (1992) Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti-HPV monoclonal antibody. J Pathol 168:293–300. doi:10.1002/path.1711680309 PubMedCrossRef Iwasaki T, Sata T, Sugase M, Sato Y, Kurata T, Suzuki K, Ohmoto H, Iwamoto S, Matsukura T (1992) Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti-HPV monoclonal antibody. J Pathol 168:293–300. doi:10.​1002/​path.​1711680309 PubMedCrossRef
15.
Zurück zum Zitat Fujii H, Yoshida M, Gong ZX, Matsumoto T, Hamano Y, Fukunaga M, Hruban RH, Gabrielson E, Shirai T (2000) Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 60:114–120PubMed Fujii H, Yoshida M, Gong ZX, Matsumoto T, Hamano Y, Fukunaga M, Hruban RH, Gabrielson E, Shirai T (2000) Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 60:114–120PubMed
Metadaten
Titel
Uterine cervical carcinosarcoma with heterologous mesenchymal component: a case report and review of the literature
verfasst von
Kyuichi Kadota
Reiji Haba
Masashi Ishikawa
Yoshio Kushida
Naomi Katsuki
Toshitetsu Hayashi
Yumi Miyai
Kenji Bando
Atsuko Shiota
Toshiyuki Hata
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1017-0

Weitere Artikel der Ausgabe 5/2009

Archives of Gynecology and Obstetrics 5/2009 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.